GMO Pepabo, Inc.
TSE:3633.T
1361 (JPY) • At close September 18, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) JPY.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 10,903.608 | 10,531.259 | 11,879.94 | 11,014.036 | 8,943.032 | 8,200.997 | 7,365.338 | 6,890.214 | 5,697.805 | 4,533.716 | 4,165.109 | 3,809.427 | 3,418.742 | 3,100.624 | 2,721.215 | 2,214.42 |
| Cost of Revenue
| 4,972.504 | 4,454.892 | 5,147.306 | 4,532.503 | 3,691.744 | 3,292.859 | 2,929.27 | 2,978.56 | 2,628.047 | 2,121.286 | 1,913.211 | 1,750.128 | 1,598.176 | 1,523.598 | 1,202.282 | 959.951 |
| Gross Profit
| 5,931.104 | 6,076.367 | 6,732.634 | 6,481.533 | 5,251.288 | 4,908.138 | 4,436.068 | 3,911.654 | 3,069.758 | 2,412.43 | 2,251.898 | 2,059.299 | 1,820.566 | 1,577.026 | 1,518.933 | 1,254.469 |
| Gross Profit Ratio
| 0.544 | 0.577 | 0.567 | 0.588 | 0.587 | 0.598 | 0.602 | 0.568 | 0.539 | 0.532 | 0.541 | 0.541 | 0.533 | 0.509 | 0.558 | 0.567 |
| Reseach & Development Expenses
| 29.144 | 29.611 | 30.445 | 33.012 | 27.03 | 24.591 | 19.104 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 5,355.948 | 4,260.452 | 4,939.887 | 4,660.711 | 3,890.739 | 0 | 0 | 2,378.434 | 1,896.095 | 1,407 | 1,333 | 1,205 | 0 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| 887 | 1,054 | 874 | 864 | 578 | 0 | 0 | 1,393 | 1,795 | 281 | 193 | 168 | 0 | 0 | 0 | 0 |
| SG&A
| 6,242.948 | 5,314.452 | 5,813.887 | 5,524.711 | 4,468.739 | 4,345.939 | 4,245.031 | 3,771.434 | 3,691.095 | 1,688 | 1,526 | 1,373 | 0 | 0 | 0 | 0 |
| Other Expenses
| 32.112 | 5,344.063 | 5,843.923 | 5,554.286 | 4,467.42 | 7.677 | 15.401 | 12.407 | 1.926 | 8.848 | 6.996 | -0.025 | 17.028 | -0.556 | 0.252 | -17.923 |
| Operating Expenses
| 6,272.092 | 5,344.063 | 5,843.923 | 5,554.286 | 4,467.42 | 4,440.409 | 4,292.402 | 3,803.34 | 3,691.094 | 1,688.017 | 1,526.152 | 1,373.206 | 1,166.652 | 954.291 | 934.962 | 796.132 |
| Operating Income
| -340.988 | 732.303 | 888.71 | 639.089 | 783.867 | 467.728 | 143.665 | 108.314 | -621.337 | 724.413 | 725.745 | 686.092 | 653.913 | 622.734 | 583.97 | 458.336 |
| Operating Income Ratio
| -0.031 | 0.07 | 0.075 | 0.058 | 0.088 | 0.057 | 0.02 | 0.016 | -0.109 | 0.16 | 0.174 | 0.18 | 0.191 | 0.201 | 0.215 | 0.207 |
| Total Other Income Expenses Net
| -54.658 | 39.12 | 176.538 | 595.184 | -63.031 | -13.547 | 12.505 | 107.683 | -132.366 | -42.175 | -48.857 | 13.807 | 46.08 | -26.015 | -0.167 | -50.434 |
| Income Before Tax
| -395.646 | 771.423 | 1,065.248 | 1,234.273 | 720.836 | 454.182 | 156.171 | 215.997 | -753.702 | 682.238 | 676.889 | 699.9 | 699.994 | 596.72 | 583.804 | 407.903 |
| Income Before Tax Ratio
| -0.036 | 0.073 | 0.09 | 0.112 | 0.081 | 0.055 | 0.021 | 0.031 | -0.132 | 0.15 | 0.163 | 0.184 | 0.205 | 0.192 | 0.215 | 0.184 |
| Income Tax Expense
| 233.141 | 284.471 | 349.833 | 404.355 | 238.787 | -12.893 | 36.352 | 62.58 | 44.051 | 271.795 | 268.61 | 303.078 | 288.409 | 245.997 | 244.35 | 169.303 |
| Net Income
| -628.787 | 510.092 | 715.415 | 829.917 | 542.746 | 467.075 | 119.82 | 153.417 | -797.754 | 410.443 | 408.279 | 396.822 | 411.585 | 350.722 | 339.453 | 238.599 |
| Net Income Ratio
| -0.058 | 0.048 | 0.06 | 0.075 | 0.061 | 0.057 | 0.016 | 0.022 | -0.14 | 0.091 | 0.098 | 0.104 | 0.12 | 0.113 | 0.125 | 0.108 |
| EPS
| -119.16 | 96.37 | 135.22 | 159.07 | 104.11 | 88.65 | 22.75 | 16.14 | -149.96 | 75.86 | 76.76 | 74.76 | 77.55 | 66.11 | 64.04 | 46.72 |
| EPS Diluted
| -119.16 | 96.37 | 134.47 | 157.86 | 103.24 | 88.55 | 22.75 | 16.14 | -149.96 | 75.79 | 76.08 | 74.42 | 77.22 | 65.9 | 64.04 | 46.51 |
| EBITDA
| 113.892 | 1,111.377 | 1,223.533 | 892.817 | 1,102.107 | 711.63 | 355.889 | 222.534 | -198.108 | 932.652 | 928.76 | 794.527 | 741.916 | 756.215 | 639.544 | 521.818 |
| EBITDA Ratio
| 0.01 | 0.106 | 0.103 | 0.081 | 0.123 | 0.087 | 0.048 | 0.032 | -0.035 | 0.206 | 0.223 | 0.209 | 0.217 | 0.244 | 0.235 | 0.236 |